Plasminogen activator Inhibitor-1 in systemic sclerosis: A nexus of fibrosis, vasculopathy, and senescence. [PDF]
Takahashi T, Takahashi T, Asano Y.
europepmc +1 more source
Roles of plasminogen activator inhibitor-1 in aging-related muscle and bone loss in mice. [PDF]
Ohira T +7 more
europepmc +1 more source
Acute portal vein thrombosis in an elderly man with homozygous mutations of plasminogen activator inhibitor-1 and methylenetetrahydrofolate reductase genes. [PDF]
Chen J, Zhao H, Yang S, Lu H, Qi X.
europepmc +1 more source
Myocardial Infarction in a Patient With Homozygous Plasminogen Activator Inhibitor-1 (PAI-1) 4G/4G Mutation: A Case Report. [PDF]
Manasrah A +4 more
europepmc +1 more source
Targeting autophagy and plasminogen activator inhibitor-1 increases survival and remodels the tumor microenvironment in glioblastoma. [PDF]
Shifman SG +8 more
europepmc +1 more source
Sustained Expression of Plasminogen Activator Inhibitor-1 in Patients Recovered from COVID-19 Disease. [PDF]
Mayer O +7 more
europepmc +1 more source
Hepatic AhR Activation by TCDD Induces Obesity and Steatosis via Hepatic Plasminogen Activator Inhibitor-1 (PAI-1). [PDF]
Oh SJ +5 more
europepmc +1 more source
The Antifibrotic Effects of Plasminogen Activator Inhibitor-1 Antagonists are Observed in Rats with Epidural Fibrosis. [PDF]
Bektasoglu PK +4 more
europepmc +1 more source
Role of plasminogen activator inhibitor-1 (PAI-1) in age-related cardiovascular pathophysiology. [PDF]
Khoddam A, Vaughan D, Wilsbacher L.
europepmc +1 more source
Serum Levels of Plasminogen Activator Inhibitor-1 in Patients with Parkinson's Disease. [PDF]
Tanrikulu AM, Ozdilek B, Agirbasli M.
europepmc +1 more source

